ALEXANDER IVACHTCHENKO, Prof., DSc. Founder of ChemDiv, Chief Scientific Officer, Founding Memeber of Scientific Advisory Board
Professor Ivachtchenko is the founder of ChemDiv, Chief Scientific Officer and the founding member of the Scientific Advisory Board. He is the recipient of multiple European awards in the field of heterocyclic chemistry and has earned the prestigious title of Honored Inventor of the Russian Federation. Professor Ivachtchenko has a PhD in Chemistry from the Institute of Chemical Industry, a DSc in Chemistry from Mendeleev University of Chemical Technology. He is the author of 4 text books, 173 scientific papers and 141 patent applications.
MICHAEL BROWNSTEIN, Prof., M.D., Ph.D. Scientific Advisor, Consultant
M.D., Ph.D. brings over thirty years of experience as a scientific leader in the fields of genetics, endocrinology, pharmacology and drug development. Dr. Brownstein earned his bachelor’s degree from Columbia University and completed his medical training at University of Chicago, where he received his M.D. and Ph.D. in pharmacology. Dr. Brownstein has held leadership positions at NIH as Chief of the Laboratory of Genetics, NIMH/NHGIR, where he led the Brain Molecular Anatomy Project and the Molecular Gene Collection Project. He subsequently directed the Functional Genomics Program at the Venter Institute. Dr. Brownstein serves on numerous scientific and policy advisory boards has authored more than 200 research publications, and has founded several successful companies. His contributions have been recognized with the Distinguished Service Award for Biomedical Research, the Arthur S. Flemming Award, and the E. Gelhorn Prize in Neurophysiology, among other honors.
HUGO KUBINYI, Prof., DSc. Consultant, University of Heidelberg
Professor Kubinyi is a member of the SAB of ChemDiv and currently the Professor of Pharmaceutical Chemistry at the University of Heidelberg. He has previously held the Chair of The QSAR and Modeling Society was an IUPAC Fellow and has been a prominent member of the QSAR and Molecular Modeling Society for 40 years. For 35 years he was responsible for the Molecular Modeling, X-ray Crystallography and Drug Design groups at BASF Pharmaceuticals. Professor Kubinyi has a PhD in Biochemistry from the Max Planck Institute and is the author of 5 text books, 90 scientific papers.
TUDOR OPREA, Prof., Ph.D., M.D. Consultant, University of New Mexico
Professor Oprea is a member of the SAB of ChemDiv and is currently Professor and Chief of the Division of Bio-computing at the University of New Mexico, School of Medicine in Albuquerque. Previously he was founder of Sunset Molecular Discovery LLC (SMDL), spent six years with AstraZeneca in Sweden and completed a successful academic tenure at the West University of Timisoara, Romania (1996-2003). Professor Oprea has an MD in general medicine and a PhD in molecular physiology from the “Victor Babes” University of Medicine and Pharmacy in Timisoara, Romania. He is the author or co-author of 13 book chapters, 43 scientific papers and 1 patent application.
Y.YAMAMOTO, Prof., DSc. Consultant, Tohoku University
Professor Yamomoto is a member of the SAB of ChemDiv. His major research interests include the development of new synthetic reactions using organometallic reagents and catalysts, natural product synthesis and medicinal chemistry, and asymmetric & stereoselective syntheses. Professor Yamomoto is the recipient of the Chemical Society of Japan Award (1996), and the Humboldt Research Award (2002).
KEY OPINION LEADERS AND CONSULTANTS
CHRISTOPH SEEGER, M.D., Ph.D.
Fox Chase Cancer Center, Philadelphia Flaviviruses
FRANCIS CHISARI, Prof., M.D.
Head of Laboratory of Experimental Virology at Scripps Clinic, San Diego Virology
RUBEN DONIS, Prof., Ph.D./D.V.M.
Adjunct Professor of Pathology and Laboratory Medicine and Influenza Section, Centers for Disease Control and Prevention, Atlanta
Influenza drug discovery
CYNTHIA LEMERE, Prof., Ph.D
Associate Professor of Neurology, Harvard Medical School Medical School and an Associate Neuroscientist at Brigham & Women’s Hospital in the Center for Neurologic Diseases (CND) Neurology
ELIEZER MASLIAH, M.D.
Professor of Neuroscience and Pathology Neurology
MICHAEL MANNS, Prof., M.D.
Hannover School of Medicine, Germany Antiviral
VLADIMIR KUKES, M.D., Ph.D.
Director of Clinical Pharmacology institute Regulatory. Pre-Clinical/Early Clinical
Dr. VERA BELOLIPETSKAYA
Study Coordinator. Conducted >200 Phase I and bioequivalence studies Regulatory. Pre-Clinical/Early Clinical
ALEKSEY MAZUS, Prof., M.D.
Director of Moscow Center for HIV Prevention Antiviral
ALEKSANDER TIGANOV, Prof., M.D.
Director of National Scientific Center of Mental Health, Principal Psychiatrist of Russian Ministry of Health. CNS
YURY ALEKSANDROVSKY, Prof.
Deputy Head of Moscow Serbsky Institute of Social and Forensic Psychiatry CNS
SERGEY TYULYANDIN, Prof.
Deputy Director of Institute of Clinical Oncology (Blokhin’s Oncocenter) Oncology
Dr. MARGARITA A. MOROZOVA
Head of Laboratory of Psychopharmacology, Russian Academy of Mental Health Research Center Psychopharmacology